Dr. Jing-zhou Hou
Overview
Jing-Zhou Hou, MD, PhD, is a clinical hematological oncologist specializing in hematological malignancies, cell therapy, and bone marrow transplant in the Mario Lemieux Center for Blood Cancers at UPMC Hillman Cancer Center. Dr. Hou received his medical degree from Henan Medical University in China, his master’s degree at Shanghai Medical University, and his PhD in Molecular and Cell Biology from Tulane University. He completed his internal medicine residency in Northeastern Ohio University College of Medicine, and fellowship in Hematology and Oncology at Stanford University. He joined UPMC Hillman Cancer Center in 2007.
Dr. Hou is rated as an Experienced provider by MediFind in the treatment of Small Lymphocytic Lymphoma (SLL). His top areas of expertise are Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant.
His clinical research consists of co-authoring 5 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Small Lymphocytic Lymphoma (SLL).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5115 Centre Avenue, Hillman Cancer Center, Pittsburgh, PA 15232
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
UPMC Hillman Cancer Center
Stanley Marks, MD, specializes in hematology oncology and medical oncology and is board-certified in hematology and internal medicine by the American Board of Internal medicine. Dr. Marks completed his medical degree at the University of Pittsburgh School of Medicine. He completed his residency training at Presbyterian Hospital, and fellowship training in clinical medicine and research medicine at Peter Bent Brigham Hospital, Harvard Medical School and Dana Farber Cancer Center. He has received numerous awards including the Golden Apple Award for Outstanding Dedication to Housestaff Education from Allegheny General Hospital, Hillel Academy Outstanding Alumnus, and The Winged Victory of Samothrace Award from the Leukemia, Lymphoma Society of Western Pennsylvania. Dr. Marks is rated as a Distinguished provider by MediFind in the treatment of Small Lymphocytic Lymphoma (SLL). His top areas of expertise are Non-Hodgkin Lymphoma, Primary Lymphoma of the Brain, Gastric Lymphoma, and Follicular Lymphoma.
Trinity Tony Teramana Medical Oncology, In Partnership With UPMC Hillman Cancer Center
Dr. Rahman is a clinical assistant professor in the Department of Medicine at the University of Pittsburgh School of Medicine. He joined UPMC Hillman Cancer Center in the year 2000. Dr. Rahman is rated as a Distinguished provider by MediFind in the treatment of Small Lymphocytic Lymphoma (SLL). His top areas of expertise are Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Paget Disease of the Breast, Bone Marrow Aspiration, and Endoscopy.
UPMC Hillman Cancer Center
Nitin Kapoor, DO, is a hematologist/medical oncologist at UPMC Hillman Cancer Center. He specializes in general hematology and oncology disorders. Dr. Kapoor is rated as a Distinguished provider by MediFind in the treatment of Small Lymphocytic Lymphoma (SLL). His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Childhood Iron Deficiency Anemia, Parathyroidectomy, and Hormone Replacement Therapy (HRT).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Hou isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Multiple MyelomaDr. Hou isDistinguished. Learn about Multiple Myeloma.
- Non-Hodgkin LymphomaDr. Hou isDistinguished. Learn about Non-Hodgkin Lymphoma.
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloblastic Leukemia with Maturation
- Acute Promyelocytic Leukemia
- Adult Immune Thrombocytopenia
- Adult T-Cell LeukemiaDr. Hou isAdvanced. Learn about Adult T-Cell Leukemia.
- B-Cell LymphomaDr. Hou isAdvanced. Learn about B-Cell Lymphoma.
- Experienced
- Acute Eosinophilic PneumoniaDr. Hou isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Monoblastic Leukemia (AmoL)Dr. Hou isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Mountain SicknessDr. Hou isExperienced. Learn about Acute Mountain Sickness.
- AgranulocytosisDr. Hou isExperienced. Learn about Agranulocytosis.
- AnemiaDr. Hou isExperienced. Learn about Anemia.
- Angioimmunoblastic T-cell Lymphoma